Reversible onychomadesis following exposure to carbamazepine.
Department of Neurology, Central India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Neeraj N
NN
Baheti
Dinesh
D
Kabra
Nitin H
NH
Chandak
B D
BD
Mehta
Rajesh R
RR
Agrawal
D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D002648:Child; D006801:Humans; D008297:Male; D056684:Yellow Nail Syndrome / Q000139:chemically induced* / Q000175:diagnosis
D000927:Anticonvulsants; D002220:Carbamazepine